Email This Press Releases

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Investor Notice: Lawsuit Alleges Securities Laws Violations

An investor, who purchased shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), filed a lawsuit over alleged violations of Federal Securities Laws by Aurinia Pharmaceuticals Inc.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy